
About Lannett
Lannett is a publicly listed company based in Philadelphia (United States) founded in 1942. Generic pharmaceuticals are manufactured, and CDMO services are offered. Lannett has completed 2 acquisitions, including Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals. Its chief executive, as recorded, is Timothy Crew. Its website lannett.com draws about 18 thousand monthly visits. Lannett offers products and services including Generic Pharmaceuticals and CDMO Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Lannett Company, Inc.
Company details
Lannett was founded in 1942 and is headquartered in Philadelphia, United States. Operations focus on the pharmaceutical sector, where generic medications for multiple therapeutic areas are developed and produced. Contract development and manufacturing organization (CDMO) services are provided to partners, including collaborations on co-development, distribution agreements, licensing arrangements, and acquisitions. Emphasis is placed on quality and affordability in product delivery.
- Headquarters Philadelphia, United States
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website lannett.com
- Social LinkedIn
- Legal Name Lannett Company, Inc
- Annual Revenue$340.58 M (USD)-29as on Jun 30, 2022
- Net Profit-$231.62 M (USD)36as on Jun 30, 2022
- EBITDA-$176.27 M (USD)26as on Jun 30, 2022
- Latest Funding Round$27.96M (USD), Post-IPO
May 2021
- Investments & AcquisitionsKremers Urban Pharmaceuticals
& 1 more
Products & Services of Lannett
Lannett offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and CDMO Services.
Generic drugs are manufactured and supplied by Lannett for various therapeutic needs, focusing on affordability and quality
Contract development and manufacturing services are provided by Lannett to support the creation of pharmaceutical products for partners
Funding Insights of Lannett
- Total Rounds 3
- Last Round Post-IPO β $27.96M
- First Round $30.5M
(May 2019)
All 3 funding rounds of Lannett with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $27.96M | Post-IPO | β | β | β |
| Sep 2019 | $86.25M | Post-IPO | β | β | β |
| May 2019 | $30.5M | Debt – Conventional | β | β | β |
People of Lannett
61 people are tracked at Lannett (23 in leadership, 3 in board & advisors, 35 in team).
| Name | Role | Group |
|---|---|---|
Timothy Crew | CEO | Leadership |
Samuel H. Israel | Chief Legal Officer & General Counsel | Leadership |
Timothy C. Crew | CEO | Leadership |
Kristie Stephens | VP of Regulatory Affairs | Leadership |
Maureen Cavanaugh | SVP & Chief Commercial Operations Officer | Leadership |
Michael Block | VP of Business Development | Leadership |
Eliene Smith | Director Of Internal Audit | Leadership |
Tracy Sullivan | Senior Director, National Accounts | Leadership |
Kristin Arnold | VP Reseach And Development | Leadership |
Freddy Rosado | Director, Pricing And Contracts | Leadership |
Matt Thompson | Director, Sales & Operation Planning | Leadership |
Helen Libman | Senior Director, Analytical R&d | Leadership |
John M. Abt | VP & Chief Quality Operations Officer | Leadership |
Kevin Higgins | Director Corporate Quality Control | Leadership |
Thomas Lewis | Vice President Of Global Supply Chain And CDMO Management | Leadership |
Bill Giannone | Vp, Marketing And Commercial Operations, Generics And Biosimilars | Leadership |
Grant Brock | Chief Operations And Strategy Officer | Leadership |
Karen Feldtmose | Senior Director Portfolio Development | Leadership |
Keith Collins | Director Quality Operations | Leadership |
Tony Meehan | Chief Financial Officer | Leadership |
41 more people are available in the full profile.
Complete people profiles for Lannett
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lannett
Lannett has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Specialty generic drugs are manufactured by Kremers Urban Pharmaceuticals. | kremersurban.com | Seymour, United States | 1904 | Sep 2015 | $1.23B | |
Manufacturer of generic drugs | silarx.com | Valley Cottage, United States | 1987 | May 2015 | β’β’β’β’ |
Complete acquisition details for Lannett
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Lannett
6 dated milestones of Lannett across 79 years, from founding to its latest funding, stage changes and deals.
- Founded Lannett is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Silarx Pharmaceuticals.
- Acquisition Acquires Kremers Urban Pharmaceuticals.
- Funding First funding round of $30.5M.
- Funding Latest funding round, Post-IPO, of $28.0M.
Web traffic of Lannett
The website of Lannett (lannett.com) receives about 18.2K visits a month and ranks #1,443,152 among all websites worldwide, #1,872 in Biotechnology and Pharmaceuticals.
- Monthly visits18.2K
▲ 12.8% vs previous month
- Unique visitors8.2K
per month
- Global rank#1,443,152
among all websites
- Category rank#1,872
Health · Biotechnology and Pharmaceuticals
- Bounce rate28%
- Pages per visit2.2
- Average visit23 sec
- DevicesDesktop 27% Β· Mobile 73%
Websites whose visitors overlap most with Lannett. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| tevausa.com | 100% | 63.7K | #703,532 | View details | |
hemispherx.net | hemispherx.net | 96% | #13,055,489 | β | |
| impaxlabs.com | 86% | View details | |||
| hauserpharmaceutical.com | 86% | 1.9K | #8,413,504 | View details | |
globalphar.com | globalphar.com | 85% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 16 similar websites and full traffic analytics for Lannett
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Lannett (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lannett
Complete news archive for Lannett
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lannett
Lannett was founded in 1942 and raised its 1st funding round 77 years after it was founded.
Lannett is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Timothy Crew is the CEO of Lannett, as recorded in our data.
Annual revenue of Lannett is $340.58M as on Jun 30, 2022.
Lannett was founded in 1942 and is headquartered in Philadelphia, United States. Operations focus on the pharmaceutical sector, where generic medications for multiple therapeutic areas are developed and produced. Contract development and manufacturing organization (CDMO) services are provided to partners, including collaborations on co-development, distribution agreements, licensing arrangements, and acquisitions. Emphasis is placed on quality and affordability in product delivery.
Lannett offers Generic Pharmaceuticals and CDMO Services.
Lannett has made 2 acquisitions, including Kremers Urban Pharmaceuticals, and Silarx Pharmaceuticals.
Lannett operates through Lannett Company, Inc.
